Sign up to our newsletter Subscribe
After the Transplant: Potential Benefits for the NHS and UK Kidney Transplant Patients

New medicines lead to improved patient outcomes and societal benefits, but R&D is a long and costly process. Ongoing health economics research aims to find the right balance between incentivising manufacturers to innovate and ensuring affordable access for health systems.